Novo ousts CEO Jorgensen after Lilly competition hits shares
10
6
16.05.2025
Lars Fruergaard Jorgensen's departure follows a 53% decline in Novo Nordisk's share price over the past 12 months and growing competition from Eli Lilly.
© Fortune
visit website